Status:
RECRUITING
Comprehensive Management of High-risk PopuLatIon of Stroke Based on Social Network
Lead Sponsor:
Changhai Hospital
Conditions:
Stroke
Cerebrovascular Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effectiveness of social network in improving drug compliance and risk factors control rate of stroke high-risk population after discharge.
Detailed Description
Stroke is the leading cause of death among residents in China, with the characteristics of high morbidity, high mortality, high disability rate, high recurrence rate and so on, which brings huge econo...
Eligibility Criteria
Inclusion
- Age ≥18 years
- High-risk population of stroke for hospitalization
- Modified Rankin Scale score≤ 2
- Patients or primary caregiver have smart phone and wechat accounts
- Patients take at least one drug for a long time (antihypertensive, hypoglycemic, lipid-lowering, anticoagulant, antiplatelet drugs)
- Written informed consent
Exclusion
- Patients and their families are unable to operate smartphones
- Having other diseases that interfere with clinical follow-up assessment (such as cancer, dementia, severe mental illness, etc.)
- Life expectancy is less than 12 months
- Patients living in the absence of network conditions
Key Trial Info
Start Date :
July 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
720 Patients enrolled
Trial Details
Trial ID
NCT05963828
Start Date
July 18 2023
End Date
June 30 2025
Last Update
June 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, Shanghai Municipality, China, 200433